Skip to main content
. 2015 Jun 16;14:81. doi: 10.1186/s12933-015-0243-y

Fig. 3.

Fig. 3

Effects of rivaroxaban on human EPC migration in vitro. a The cell viability assays evaluated the toxicity of rivaroxaban in late EPC proliferation. b The migratory function of EPCs was evaluated using a scratch injury model. Data are the mean ± SEM. (*P < 0.05 compared with control, # P < 0.05 compared with hyperglycemic conditions, n = 4 for each experiment)